Teladoc Health, Inc. (LON:0LDR)
8.53
+0.20 (2.36%)
At close: Oct 23, 2025
Teladoc Health Revenue
Teladoc Health had revenue of $631.90M USD in the quarter ending June 30, 2025, a decrease of -1.64%. This brings the company's revenue in the last twelve months to $2.54B, down -2.57% year-over-year. In the year 2024, Teladoc Health had annual revenue of $2.57B, down -1.26%.
Revenue (ttm)
$2.54B
Revenue Growth
-2.57%
P/S Ratio
0.61
Revenue / Employee
$462.23K
Employees
5,500
Market Cap
1.14B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
| Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
| Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
| Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
| Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Teladoc Health News
- 6 days ago - Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know - Nasdaq
- 7 days ago - Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health - Nasdaq
- 8 days ago - Zacks.com featured highlights include United Natural Foods, Teladoc Health, Supernus and BRP - Nasdaq
- 8 days ago - Teladoc Health to Announce Third Quarter 2025 Financial Results - GlobeNewsWire
- 8 days ago - Can 4 Relative Price Strength Stocks Defy Market Swings? - Nasdaq
- 9 days ago - Teladoc (TDOC) Just Reclaimed the 200-Day Moving Average - Nasdaq
- 9 days ago - Teladoc Health Expands Clarity Platform With Workplace Safety Tool - Nasdaq
- 9 days ago - Looking for a Fast-paced Momentum Stock at a Bargain? Consider Teladoc (TDOC) - Nasdaq